Maxigesic on track to access the large United States painkiller market

AFT Pharmaceuticals has been officially notified that the US Food and Drug Administration (FDA) has accepted its application to register its painkiller Maxigesic tablets in the United States.
AFT Board Director and drug development expert, Dr Doug Wilson, says that this notification is a significant milestone in getting Maxigesic into the key US market.